Advanced Prostate Cancer VL

Non-Controversial Topics in Prostate Cancer - William Oh

Details
William Oh, MD Chief of Division of Hematology and Medical Oncology, Deputy Director of The Tisch Cancer Institute, Professor of Medicine and Urology at Icahn School of Medicine at Mount Sinai in New York Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Debate Position: Optimal Rx for Oligometastatic Disease is Multimodality - Charles Ryan

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Arbiter: Oligometastatic Disease - Robert Bristow

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

An Example With Oligometastatic Prostate Cancer - Bertrand Tombal

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Perspective on Surgery - Borges Dos Reis Rodolfo

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Adjuvant Therapy in High-Risk Prostate Cancer after Radical Prostatectomy - Robert Bristow

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Debate: Comparative Effectiveness of Surgery versus Radiation- Laurence Klotz

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October. Laurence Klotz, MD and Mack Roach, III , MD presented a debate on “Comparative Effectiveness of Surgery and Radiation: Surgery Is Better” versus “Radiotherapy Yields Better Oncologic Outcomes than Radical Prostatectomy for Clin...

Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer- Karim Fizazi

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October. Karim Fizazi, MD presents, “Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer” and discusses mechanisms of resistance to ADT with CRPC, mechanisms of CRPC resistance to new drugs and mechanisms of resis...

ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6) E. David Crawford presents the potential mechanisms for differences in cardiovascular risk with different forms of ADT including; metabolic status, exacerbation of underlying cardiovascular disease (CVD) and preclinical data. In addition, a discussion on the need for the risk of CVD to be assessed...

When and How to Use Salvage Radiation Therapy in Biochemical Recurrence - Alberto Bossi

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer